Target intelligence / Profile preview

Cysteine-containing thiol compound

Molecular classification
Other
01

Overview

Cysteine-containing thiol compounds are a chemically and functionally diverse group of molecules featuring a sulfhydryl (–SH) group attached to a cysteine or cysteine-derived backbone. These compounds—including cysteine itself, glutathione, coenzyme A, and penicillamine—play essential roles in biological systems, acting as antioxidants, cofactors, and contributors to protein structure via disulfide bond formation[1][3][4][8]. The thiol group is highly nucleophilic and easily oxidized, making these compounds critical for maintaining cellular redox balance and protecting against oxidative stress[1][5][9]. They participate in detoxification, metal ion homeostasis, and enzymatic catalysis. Disruption or depletion of cysteine-containing thiols is associated with various diseases, including neurodegenerative disorders and cancer[1][3]. Several drugs act on or are mimics of these thiol compounds, notably N-acetylcysteine (for acetaminophen overdose and mucolysis) and penicillamine (for chelation therapy)[1][2]. However, "cysteine-containing thiol compounds" is not a single molecular target but an umbrella term for a class of chemically related molecules, so it does not correspond to a unified protein, receptor, or enzyme. Rather, it denotes a structural motif present in many different molecules with wide-ranging, often interrelated biological activities[2][3][4][8].

Other names
Cysteine thiolsLow-molecular-mass thiolsLMM thiolsSulfhydryl compoundsMercaptans
02

Mechanism of action

Redox modulation/antioxidant effect; Heavy metal chelation; Disulfide bond disruption; Free radical scavenging

03

Biological functions

Redox regulationAntioxidant activity (via glutathione)Disulfide bond formation in proteinsEnzymatic catalysis/cofactor activityMetal binding/homeostasisSignal transduction modulation
04

Disease associations

Oxidative stress-related diseasesNeurodegenerative diseaseCancerCardiovascular diseaseInflammation
05

Safety considerations

Risk of toxicity with excessive supplementation (e.g., nephrotoxicity, oxalate kidney stones from cysteine)Allergic reactions (for drugs derived from cysteine)Reductive stress if excessive reducing agents are used
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Glutathione (GSH/GSSG ratio)Plasma cysteine/cystine levelsTotal thiol content in serum

Beyond the preview

Go deeper on Cysteine-containing thiol compound.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cysteine-containing thiol compound.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call